Goldfinger M, Mantzaris I, Shastri A, Rockwell B, Saunthararajah Y, Yin S, Levitz D, Gritsman K, Sica AR, Kornblum N, Shapiro LC, Gupta R, Peeke S, Shah N, Pradhan K, Munoz A, Dhawan A, Verceles JA, Fehn K, Comas M, Shah L, Shi Y, Jonas BA, Cooper DL, Konopleva M, Feldman EJ, Verma A. Treatment of TP53-mutated myelodysplastic syndrome and acute myeloid leukemia with low-intensity metronomic decitabine and venetoclax. haematol [Internet]. 2026Oct.1 [cited 2026Oct.7];111(10):3308-17. Available from: https://haematologica.org/article/view/13443